IL-17-producing Vγ4+ γδ T cells require sphingosine 1-phosphate receptor 1 for their egress from the lymph nodes under homeostatic and inflammatory conditions

Journal of Immunology

Volumn 195, Issue 4, 2015, Pages 1408-1416

  Maeda, Yasuhiro ^a   Seki, Noriyasu ^a   Kataoka, Hirotoshi ^a   Takemoto, Kana ^a   Utsumi, Hiroyuki ^a   Fukunari, Atsushi ^a   Sugahara, Kunio ^a   Chiba, Kenji ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FINGOLIMOD; INTERLEUKIN 17; SPHINGOSINE 1 PHOSPHATE RECEPTOR; TOLL LIKE RECEPTOR AGONIST; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIGEN RECEPTOR; MEMBRANE-BOUND TRANSCRIPTION FACTOR PEPTIDASE, SITE 1; SERINE PROTEINASE; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL EXPANSION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG MECHANISM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; GAMMA DELTA T LYMPHOCYTE; HOMEOSTASIS; INFLAMMATION; LYMPH NODE; LYMPHOCYTE MIGRATION; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE SUBPOPULATION; AGONISTS; ANIMAL; BIOSYNTHESIS; CELL MOTION; DERMATITIS; DISEASE MODEL; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; PATHOLOGY;

ANIMALS; CELL MOVEMENT; DERMATITIS; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FINGOLIMOD HYDROCHLORIDE; HOMEOSTASIS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; INTERLEUKIN-17; LYMPH NODES; MALE; MICE; PROPROTEIN CONVERTASES; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RECEPTORS, LYSOSPHINGOLIPID; SERINE ENDOPEPTIDASES; T-LYMPHOCYTE SUBSETS; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTOR 8;

EID: 84938908670     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500599     Document Type: Article

References (47)

1. Kappos, L., E. W. Radue, P. O'Connor, C. Polman, R. Hohlfeld, P. Calabresi, K. Selmaj, C. Agoropoulou, M. Leyk, L. Zhang-Auberson, and P. Burtin, FREEDOMS Study Group. 2010. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N. Engl. J. Med. 362: 387-401.
2. Cohen, J. A., F. Barkhof, G. Comi, H. P. Hartung, B. O. Khatri, X. Montalban, J. Pelletier, R. Capra, P. Gallo, G. Izquierdo, et al; TRANSFORMS Study Group. 2010. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N. Engl. J. Med. 362: 402-415.
3. Matloubian, M., C. G. Lo, G. Cinamon, M. J. Lesneski, Y. Xu, V. Brinkmann, M. L. Allende, R. L. Proia, and J. G. Cyster. 2004. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor. Nature 427: 355-360.
4. Chiba, K. 2005. FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors. Pharmacol. Ther. 108: 308-319.
5. Maeda, Y., H. Matsuyuki, K. Shimano, H. Kataoka, K. Sugahara, and K. Chiba. 2007. Migration of CD4 T cells and dendritic cells toward sphingosine 1-phosphate (S1P) is mediated by different receptor subtypes: S1P regulates the functions of murine mature dendritic cells via S1P receptor type. J. Immunol. 178: 3437-3446.
6. Oo, M. L., S. Thangada, M. T. Wu, C. H. Liu, T. L. Macdonald, K. R. Lynch, C. Y. Lin, and T. Hla. 2007. Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor. J. Biol. Chem. 282: 9082-9089.
7. Ferber, I. A., S. Brocke, C. Taylor-Edwards, W. Ridgway, C. Dinisco, L. Steinman, D. Dalton, and C. G. Fathman. 1996. Mice with a disrupted IFN-g gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 156: 5-7.
8. Park, H.,Z. Li, X. O. Yang, S. H. Chang,R.Nurieva, Y.-H. Wang, Y.Wang,L.Hood, Z. Zhu, Q. Tian, and C. Dong. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin. Nat. Immunol. 6: 1133-1141.
9. Harrington, L. E., R. D. Hatton, P. R. Mangan, H. Turner, T. L. Murphy, K. M. Murphy, and C. T. Weaver. 2005. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6: 1123-1132.
10. Brinkmann, V. 2009. FTY720 (fingolimod) in multiple sclerosis: therapeutic effects in the immune and the central nervous system. Br. J. Pharmacol. 158: 1173-1182.
11. Mehling, M., R. Lindberg, F. Raulf, J. Kuhle, C. Hess, L. Kappos, and V. Brinkmann. 2010. Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis. Neurology 75: 403-410.
12. Webb, M., C.-S. Tham, F.-F. Lin, K. Lariosa-Willingham, N. Yu, J. Hale, S. Mandala, J. Chun, and T. S. Rao. 2004. Sphingosine 1-phosphate receptor agonists attenuate relapsing-remitting experimental autoimmune encephalitis in SJL mice. J. Neuroimmunol. 153: 108-121.
13. Kataoka, H., K. Sugahara, K. Shimano, K. Teshima, M. Koyama, A. Fukunari, and K. Chiba. 2005. FTY720, sphingosine 1-phosphate receptor modulator, ameliorates experimental autoimmune encephalomyelitis by inhibition of T cell infiltration. Cell. Mol. Immunol. 2: 439-448.
14. Chiba, K., H. Kataoka, N. Seki, K. Shimano, M. Koyama, A. Fukunari, K. Sugahara, and T. Sugita. 2011. Fingolimod (FTY720), sphingosine 1-phosphate receptor modulator, shows superior efficacy as compared with interferon-b in mouse experimental autoimmune encephalomyelitis. Int. Immunopharmacol. 11: 366-372.
15. Seki, N., Y. Maeda, H. Kataoka, K. Sugahara, and K. Chiba. 2013. Role of sphingosine 1-phosphate (S1P) receptor 1 in experimental autoimmune encephalomyelitis-I. Pharmacol. Pharm. 4: 628-637.
16. Martin, B., K. Hirota, D. J. Cua, B. Stockinger, and M. Veldhoen. 2009. Interleukin-17-producing gd T cells selectively expand in response to pathogen products and environmental signals. Immunity 31: 321-330.
17. Sutton, C. E., S. J. Lalor, C. M. Sweeney, C. F. Brereton, E. C. Lavelle, and K. H. Mills. 2009. Interleukin-1 and IL-23 induce innate IL-17 production from gd T cells, amplifying Th17 responses and autoimmunity. Immunity 31: 331-341.
18. Stark, M. A., Y. Huo, T. L. Burcin, M. A. Morris, T. S. Olson, and K. Ley. 2005. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 22: 285-294.
19. Witherden, D. A., and W. L. Havran. 2011. Molecular aspects of epithelial gd T cell regulation. Trends Immunol. 32: 265-271.
20. Vantourout, P., and A. Hayday. 2013. Six-of-the-best: unique contributions of gd T cells to immunology. Nat. Rev. Immunol. 13: 88-100.
21. Battistini, L., K. Selmaj, C. Kowal, J. Ohmen, R. L. Modlin, C. S. Raine, and C. F. Brosnan. 1995. Multiple sclerosis: limited diversity of the Vd2-Jd3 T-cell receptor in chronic active lesions. Ann. Neurol. 37: 198-203.
22. Stinissen, P., C. Vandevyver, R. Medaer, L. Vandegaer, J. Nies, L. Tuyls, D. A. Hafler, J. Raus, and J. Zhang. 1995. Increased frequency of gd T cells in cerebrospinal fluid and peripheral blood of patients with multiple sclerosis. Reactivity, cytotoxicity, and T cell receptor V gene rearrangements. J. Immunol. 154: 4883-4894.
23. Jensen, K. D., X. Su, S. Shin, L. Li, S. Youssef, S. Yamasaki, L. Steinman, T. Saito, R. M. Locksley, M. M. Davis, et al. 2008. Thymic selection determines gd T cell effector fate: antigen-naive cells make interleukin-17 and antigenexperienced cells make interferon g. Immunity 29: 90-100.
24. Blink, S. E., M. W. Caldis, G. E. Goings, C. T. Harp, B. Malissen, I. Prinz, D. Xu, and S. D. Miller. 2014. gd T cell subsets play opposing roles in regulating experimental autoimmune encephalomyelitis. Cell. Immunol. 290: 39-51.
25. Roark, C. L., P. L. Simonian, A. P. Fontenot,W. K. Born, and R. L. O'Brien. 2008. gd T cells: an important source of IL-17. Curr. Opin. Immunol. 20: 353-357.
26. Hirota, K., J. H. Duarte, M. Veldhoen, E. Hornsby, Y. Li, D. J. Cua, H. Ahlfors, C. Wilhelm, M. Tolaini, U. Menzel, et al. 2011. Fate mapping of IL-17-producing T cells in inflammatory responses. Nat. Immunol. 12: 255-263.
27. Petermann, F., V. Rothhammer, M. C. Claussen, J. D. Haas, L. R. Blanco, S. Heink, I. Prinz, B. Hemmer, V. K. Kuchroo, M. Oukka, and T. Korn. 2010. gd T cells enhance autoimmunity by restraining regulatory T cell responses via an interleukin-23-dependent mechanism. Immunity 33: 351-363.
28. Haas, J. D., S. Ravens, S. Düber, I. Sandrock, L. Oberdörfer, E. Kashani, V. Chennupati, L. Föhse, R. Naumann, S. Weiss, et al. 2012. Development of interleukin-17-producing gd T cells is restricted to a functional embryonic wave. Immunity 37: 48-59.
29. Xiong, N., C. Kang, and D. H. Raulet. 2004. Positive selection of dendritic epidermal gd T cell precursors in the fetal thymus determines expression of skinhoming receptors. Immunity 21: 121-131.
30. Odumade, O. A., M. A. Weinreich, S. C. Jameson, and K. A. Hogquist. 2010. Krüppel-like factor 2 regulates trafficking and homeostasis of gd T cells. J. Immunol. 184: 6060-6066.
31. Gray, E. E., F. Ram?rez-Valle, Y. Xu, S. Wu, Z. Wu, K. E. Karjalainen, and J. G. Cyster. 2013. Deficiency in IL-17-committed Vg4+ gd T cells in a spontaneous Sox13-mutant CD45.1+ congenic mouse substrain provides protection from dermatitis. Nat. Immunol. 14: 584-592.
32. Kiuchi, M., K. Adachi, T. Kohara, M. Minoguchi, T. Hanano, Y. Aoki, T. Mishina, M. Arita, N. Nakao, M. Ohtsuki, et al. 2000. Synthesis and immunosuppressive activity of 2-substituted 2-aminopropane-1,3-diols and 2-aminoethanols. J. Med. Chem. 43: 2946-2961.
33. Halweg, K. M., and G. Buchi. 1985. A convenient synthesis of 2-acetyl-4(5)-(1R,2S,3R,4-tetrahydroxybutyl)imidazole. J. Org. Chem. 50: 1134-1136.
34. Arnon, T. I., Y. Xu, C. Lo, T. Pham, J. An, S. Coughlin, G. W. Dorn, and J. G. Cyster. 2011. GRK2-dependent S1PR1 desensitization is required for lymphocytes to overcome their attraction to blood. Science 333: 1898-1903.
35. Roark, C. L., J. D. French, M. A. Taylor, A. M. Bendele, W. K. Born, and R. L. O'Brien. 2007. Exacerbation of collagen-induced arthritis by oligoclonal, IL-17-producing g d T cells. J. Immunol. 179: 5576-5583.
36. Blink, S. E., and S. D. Miller. 2009. The contribution of gd T cells to the pathogenesis of EAE and MS. Curr. Mol. Med. 9: 15-22.
37. Cai, Y., X. Shen, C. Ding, C. Qi, K. Li, X. Li, V. R. Jala, H. G. Zhang, T. Wang, J. Zheng, and J. Yan. 2011. Pivotal role of dermal IL-17-producing gd T cells in skin inflammation. Immunity 35: 596-610.
38. Pantelyushin, S., S. Haak, B. Ingold, P. Kulig, F. L. Heppner, A. A. Navarini, and B. Becher. 2012. Rorgt+ innate lymphocytes and gd T cells initiate psoriasiform plaque formation in mice. J. Clin. Invest. 122: 2252-2256.
39. Seki, N., Y. Maeda, H. Kataoka, K. Sugahara, T. Sugita, and K. Chiba. 2010. Fingolimod (FTY720) ameliorates experimental autoimmune encephalomyelitis (EAE): II. FTY720 decreases infiltration of Th17 and Th1 cells into the central nervous system in EAE. Inflamm. Regen. 30: 542-548.
40. Maeda, Y., N. Seki, N. Sato, K. Sugahara, and K. Chiba. 2010. Sphingosine 1-phosphate receptor type 1 regulates egress of mature T cells from mouse bone marrow. Int. Immunol. 22: 515-525.
41. Chiba, K., Y. Yanagawa, Y. Masubuchi, H. Kataoka, T. Kawaguchi, M. Ohtsuki, and Y. Hoshino. 1998. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. J. Immunol. 160: 5037-5044.
42. Shichita, T., Y. Sugiyama, H. Ooboshi, H. Sugimori, R. Nakagawa, I. Takada, T. Iwaki, Y. Okada, M. Iida, D. J. Cua, et al. 2009. Pivotal role of cerebral interleukin-17-producing gdT cells in the delayed phase of ischemic brain injury. Nat. Med. 15: 946-950.
43. Pham, T. H., T. Okada, M. Matloubian, C. G. Lo, and J. G. Cyster. 2008. S1P1 receptor signaling overrides retention mediated by Gai-coupled receptors to promote T cell egress. Immunity 28: 122-133.
44. Grigorova, I. L., S. R. Schwab, T. G. Phan, T. H. Pham, T. Okada, and J. G. Cyster. 2009. Cortical sinus probing, S1P1-dependent entry and flow-based capture of egressing T cells. Nat. Immunol. 10: 58-65.
45. Vermijlen, D., P. Ellis, C. Langford, A. Klein, R. Engel, K. Willimann, H. Jomaa, A. C. Hayday, and M. Eberl. 2007. Distinct cytokine-driven responses of activated blood gd T cells: insights into unconventional T cell pleiotropy. J. Immunol. 178: 4304-4314.
46. Caccamo, N., C. La Mendola, V. Orlando, S. Meraviglia, M. Todaro, G. Stassi, G. Sireci, J. J. Fournié, and F. Dieli. 2011. Differentiation, phenotype, and function of interleukin-17-producing human Vg9Vd2 T cells. Blood 118: 129-138.
47. Muls, N., H. A. Dang, C. J. Sindic, and V. van Pesch. 2014. Fingolimod increases CD39-expressing regulatory T cells in multiple sclerosis patients. PLoS One 9: e113025.